Glenmark Expands Specialty Portfolio with OTIPRIO Co-Promotion Agreement in the U.S. with Otonomy for Acute Otitis Externa Indication Read more
Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers Read more
Biopharma Process Systems & NIBSC to Lead Interactive Workshops for the Lyophilisation Conference 2019 Read more
PolyProx Therapeutics Raises £3.4m Seed Financing to Validate Novel Class of Drugs to Treat Cancer Read more
Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors Read more